LivaNova Corp (LIVN): Price-to-Revenue Coefficient

Symbol and logo of brand LivaNova plc (LIVN)

LivaNova PLC is currently optimizing its operational processes, focusing on profitable neuromodulation and cardiac surgery systems. The market capitalization-to-revenue ratio reflects the market valuation of this strategy, where the 3.30 mark characterizes this parameter. Growth is supported by alliances with clinics to develop stimulators, as well as joint research with physicians into therapy methods for epilepsy and depression.

LIVN: LivaNova Price-to-Revenue Ratio 07/04/2022 - 11/14/2026

Analytical breakdowns for LivaNova Group (LIVN)

- stock value and consensus price forecast:
Stock Price livanova.com|LIVN - Price Target Chart
- stock exchange capitalization data:
Market Capitalization LivaNova Group|LIVN - Real Price to Acquire Entire Company
- company book value details:
Accounting Value of a Share LivaNova|LIVN - Company Book Value|Market Cap to Net Assets Ratio livanova.com|LIVN - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital LivaNova PLC|LIVN - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio LivaNova Corp|LIVN - Company Aggregate Debts|Debts to Net Assets LivaNova Group|LIVN - Company Long-Term Debts|Company Current Liabilities LivaNova|Quick Ratio livanova.com
- earnings and valuation multiples information:
LIVN - Company Net Income|Expected Profit LivaNova PLC|LIVN - Price to Earnings Ratio|Future Price to Earnings Multiple LivaNova plc|LIVN - PEG Multiple|Company Value to EBITDA LivaNova Group|LIVN - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year LivaNova|LIVN - Net earnings per share for the last 12 months|Quarterly EPS earnings growth livanova.com|LIVN - Earnings growth in current year|Consensus forecast of earnings per share growth for next year LivaNova PLC
- total revenue and sales volume data:
LIVN - Company Revenue|Company Expected Revenue livanova.com|LIVN - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple LivaNova Group
General company analysis:LIVN, livanova.com
Mass-produced product of livanova.com

Steady demand for LivaNova PLC (LIVN) neuromodulation and cardiac surgery systems allows for the assessment of business scaling efficiency through market value. An analysis of the price-to-sales multiple demonstrates the capitalization ratio relative to annual turnover, helping investors determine the premium paid for revenue and correlate the expansion rates of medical technologies with the current share price to identify the asset's fair value.

Competing companies

P/S Multiple stryker.com (SYK)|Price-to-Revenue Ratio Medtronic MDT|Price-to-Revenue Coefficient Royal Philips (PHG)|SNN: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio HOLX (Hologic Medical)|Carlisle Companies (CSL) - Price-to-Revenue Ratio|Market Cap to Revenue integer.net|AHCO (AdaptHealth) - P/S Multiple|Price to Sales SS Innovations International Inc SSII|P/S Multiple AVNS|shoulderinnovations.com - Market Cap to Revenue Ratio|P/S Multiple VMD (Viemed Healthcare, Inc.)|Price-to-Revenue Coefficient Inogen Inc (INGN)|Owlet Care - P/S Multiple|Quipt Home Medical Corp (QIPT) - Market Cap to Revenue|POCI: P/S Multiple|PAVmed (PAVM) - P/S Multiple|Price-to-Revenue Ratio Tivic Health Systems|Price-to-Revenue Ratio MOVE|Market Cap to Revenue NUVO (Nuvo Group)